Search results

Found 1,514 pages
AUTHOR: Anna Smith

25 Jan 2019:

Rubraca gets EU approval

Clovis Oncology' Rubraca has been approved by the European Commission for maintenance treatment of adults with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/rubraca_gets_eu_approval_1276217

11 Mar 2019:

Positive results for monthly HIV drug

Johnson & Johnson/ViiV's once-monthly, injectable drug combination for HIV shows comparable efficacy to daily oral treatment in two trials. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/positive_results_for_monthly_hiv_drug_1280938

23 Jan 2019:

GSK completes Tesaro deal

GlaxoSmithKline has completed its acquisition of Tesaro, the oncology focused biopharmaceutical company. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/gsk_completes_tesaro_deal_1275909

17 Sep 2019:

Santen’s Ikervis effective for dry eye

The treatment proved effectiveness, tolerability and safety in the PERSPECTIVE trial. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/santens_ikervis_effective_for_dry_eye_1301772

6 Dec 2018:

Shire purchase backed by Takeda shareholders

Takeda shareholders have backed the firm’s proposed £46 billion acquisition of Shire. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/shire_purchase_backed_by_takeda_shareholders_1272057

1 May 2019:

European approval for AbbVie’s Skyrizi

The approval is for the treatment of moderate to severe plaque psoriasis. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/european_approval_for_abbvies_skyrizi_1286222

20 Sep 2019:

Xospata leads latest CHMP recommendations

The committee has recommended seven medicines for approval at its September 2019 meeting. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/xospata_leads_latest_chmp_recommendations_1302120

7 Jun 2019:

Biogen completes Nightstar acquisition

The companies announced the acquisition in March this year, with the value estimated at approximately $800 million. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/biogen_completes_nightstar_acquisition_1290282

31 Jan 2020:

LEO issues Picato recall

Last September, the EMA's Pharmacovigilance Risk Assessment Committee announced a review of data on skin cancer in patients using the drug. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/leo_issues_picato_recall_1323880

29 May 2019:

Sosei get $2.5m for QVM149 MAA

The company recently announced positive data from two Phase II clinical studies, in which QVM149 was shown to be superior to the comparators. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/sosei_get_$2.5m_for_qvm149_maa_1289336